Halobetasol Propionate API

Name	Halobetasol Propionate
Chinese name	卤倍他索丙酸酯
Cas Number	66852-54-8
Source	Europe
Qualifications	/-/-/-/-

Halobetasol propionate is synthesized by Ciba-Gergy Pharmaceutical Factory in Basel, Switzerland. It is a super strong topical corticosteroid preparation and has been widely used in the United States. The clinical pharmacological studies of halobetasol propionate show that it is a unique new corticosteroid topical drug with a slightly stronger curative effect than clobetasol. Animal experiments show that the ED50 of guinea pig ultraviolet dermatitis is 1300 and 11 times stronger than that of hydrocortisone and clobetasol, respectively. After clinical application, it was found that Halobetasol propionate was well tolerated. Only a few cases had mild side effects after topical administration, and no skin atrophy and systemic side effects were found. In clinical studies, Halobetasol propionate emulsion has shown good local tolerability, lasting up to 8 weeks of treatment without affecting the efficacy. Halobetasol Propionate Emulsion was temporarily approved by the U.S. FDA on October 12, 2018, and was finally approved on November 6, as a topical treatment drug for the treatment of plaque psoriasis in adult patients , Is an important new treatment option for psoriasis patients.

Hot Tags: halobetasol propionate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Bemeprost API, Vinpocetine API, Pleasant API, Aprepitant Aprepitant API, Dapoxetine API, Pabxilib API

• Previous: Tasmetron API
• Next: Cetylpyridinium Chloride API